Chondrogen

BIOLOGICAL2 trials

Sponsors

Mesoblast International Sàrl, Meluha Life Sciences SDN BHD

Conditions

Osteoarthritis, KneeRecovery Following Partial Medial Meniscectomy

Phase 1

Follow-up Study of Chondrogen® Delivered by Intra-Articular Injection Following Meniscectomy

CompletedNCT00702741

Mesoblast International SàrlRecovery Following Partial Medial Meniscectomy

Start: 2008-06-30End: 2011-09-30Updated: 2022-01-11

Phase 2

Phase 2B Clinical Study of Chondrogen for Treatment of Knee Osteoarthritis

Meluha Life Sciences SDN BHDOsteoarthritis, Knee

Start: 2020-10-31End: 2022-09-30Target: 100Updated: 2020-08-20